Logo
Register Log in
FirstArticle-BlurbImagePath
AGA Accepting Applications for Its Inaugural Incubator Program

AUGUST 21, 2025

FirstArticle-BlurbImagePath
Wegovy Approved to Treat MASH With Moderate to Advanced Fibrosis

AUGUST 20, 2025

FirstArticle-BlurbImagePath
Highlights From DDW 2025, Part 2

AUGUST 19, 2025

Email This Article
POSTED: AUGUST 22, 2024

MASH Therapy Pipeline Growing, With a Mix of Results

After years without drug treatments for metabolic dysfunction–associated steatohepatitis, recently data have been accumulating on several agents.
A link to this article will be included in this email.
Recipient's Email Address:
Enter email addresses separated by commas if sending to more than one person. (200 characters max)
Your Name:
Your Email Address:


Personal Message: (Optional)
These email addresses will only be used to send out this message.
Please wait.. Please wait..

Hepatology in Focus

AUGUST 22, 2024

MASH Therapy Pipeline Growing, With a Mix of Results

Related Content

Survodutide Shows Significant Improvement in MASH and Liver Fibrosis in Phase 2 Trial

Patients taking the


To read the full story, Log in or Sign up for a Free Account

Log in / Sign up

Check out our new Clinical tab!

We've added an exciting new feature to our website. Click on "Clinical" in the navbar to explore!

The following result is from the NPI Registry Public Search database. You can click on the NPI number to view detailed information and verify its accuracy. If your NPI is not found in this search, you can try searching again using the form below. If you have difficulty finding your NPI number please contact us at web@mcmahonmed.com
OR

NPI Name Organization/ Institution State Zip Code Taxonomy    Credential Select